Philips and Masimo extend monitoring alliance with new AI, wearables focus

Philips and Masimo are extending their collaboration in patient monitoring, with a new multi-year agreement designed to accelerate the adoption of advanced wearable sensors and expand the use of artificial intelligence (AI) in bedside and remote monitoring technologies. The companies announced the renewal on September 11, calling it a way to deepen a relationship that has spanned more than two decades.

Masimo’s technologies — including its SET pulse oximetry, continuous hemoglobin monitoring and brain function sensors — are already integrated into Philips monitors and central stations. Under the new deal, the companies will focus on speeding up integration and offering more devices across additional market segments.

Bringing wearables into the fold

Central to the renewed partnership is Masimo’s Radius PPG, a wireless wearable sensor that tracks blood oxygen saturation. Philips will embed Masimo hardware directly into its bedside monitors, allowing clinicians to connect patients seamlessly to the wearable platform.

The companies said they will also work on next-generation, multi-parameter devices that could support monitoring beyond the hospital setting.

“Expanding our strong, long-standing partnership with Philips allows us to build on our shared legacies of innovation and helps ensure that Masimo’s best-in-class technologies reach even more patients,” Katie Szyman, CEO of Masimo, said in a statement.

An AI push in patient monitoring

The renewed agreement also includes a joint focus on developing AI-powered monitoring tools. Philips and Masimo said they plan to co-develop and promote algorithms that can help clinicians interpret patient data more quickly and respond to changing conditions.

“Our priority is helping clinicians deliver the best possible care to their patients, and that means staying ahead of the curve,” said Julia Strandberg, executive vice president and business leader for connected care at Philips. “This partnership allows us to respond quickly to evolving clinical needs and market trends, integrating proven technologies into solutions that are easy to use, reliable and scalable.”

Competitive landscape

The announcement comes two months after Philips renewed a separate patient monitoring partnership with Medtronic, a Masimo competitor. On Masimo’s second-quarter earnings call in August, analysts raised questions about whether its relationship with Philips would continue, MedTech Dive reports.

The new agreement appears intended to assure investors that the alliance remains strong, while also positioning both companies to compete more aggressively in a growing market for wearable monitoring and AI-enabled tools.

What comes next

Philips and Masimo said adoption of these technologies will accelerate through 2026 and beyond, with expanded deployment in both acute and non-acute care settings. The companies described the renewal as an effort to bring advanced monitoring to “millions more patients” worldwide, though specific timelines for product rollouts were not disclosed.

“Together, Masimo and Philips will continue to empower clinicians to transform patient care,” Szyman said.